Pfizer gives Danish PM cold shoulder: rejects idea of starting vaccine production in Denmark
Although three of the world's largest pharmaceutical companies have expressed interest in establishing vaccine production facilities in Denmark, Pfizer is not interested in working with the Danish authorities.
BY ULRICH QUISTGAARD, TRANSLATED BY CATHERINE BRETT
Although the Pfizer/Biontech vaccine is the most widely used covid-19 vaccine in Denmark, it does not look like the companies will be establishing vaccine production facilities in the country.
In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.
The US retail chain has stopped selling its own private label hearing aids – and until the next generation comes along, other hearing companies selling products via Costco are enjoying the empty shelf space.